Chromosomal abnormalities in Ph- cells of patients on imatinib. - Suppr | 超能文献

Chromosomal abnormalities in Ph- cells of patients on imatinib.

作者信息

McMullin Mary F, Humphreys Mervyn, Byrne Jenny, Russell Nigel H, Cuthbert Robert J, O'Dwyer Michael E

出版信息

Blood. 2003 Oct 1;102(7):2700-1; author reply 2701. doi: 10.1182/blood-2003-06-1943.

DOI:10.1182/blood-2003-06-1943

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Chromosomal abnormalities in Ph- cells of patients on imatinib.

Blood. 2003 Oct 1;102(7):2700-1; author reply 2701. doi: 10.1182/blood-2003-06-1943.

2

Chromosomal abnormalities in chronic myeloid leukemia: evidence of a hierarchy in imatinib treated cells.慢性髓性白血病中的染色体异常：伊马替尼治疗细胞中存在等级结构的证据。

Leuk Lymphoma. 2007 May;48(5):1029-31. doi: 10.1080/10428190701200034.

3

Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy.伊马替尼治疗失败后接受尼洛替尼治疗的慢性髓性白血病患者费城阴性造血中克隆性染色体异常的出现。

Leuk Res. 2009 Dec;33(12):e218-20. doi: 10.1016/j.leukres.2009.05.010. Epub 2009 Jun 13.

4

Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia.作为慢性粒细胞白血病患者对甲磺酸伊马替尼耐药的一种可能机制，费城染色体的复制

Cancer Genet Cytogenet. 2005 Dec;163(2):189-90. doi: 10.1016/j.cancergencyto.2005.05.004.

5

Clonal chromosome aberrations in Philadelphia-negative cells from chronic myelocytic leukemia patients treated with imatinib mesylate: report of two cases.

Cancer Genet Cytogenet. 2003 Nov;147(1):78-80. doi: 10.1016/s0165-4608(03)00198-5.

6

Persistence of chromosomal abnormalities additional to the Philadelphia chromosome after Philadelphia chromosome disappearance during imatinib therapy for chronic myeloid leukemia.

Haematologica. 2007 Apr;92(4):564-5. doi: 10.3324/haematol.10783.

7

Simultaneous regression of Philadelphia chromosome and multiple nonrecurrent clonal chromosomal abnormalities with imatinib mesylate in a patient autografted 22 years before for chronic myelogenous leukemia.

Leuk Lymphoma. 2007 Sep;48(9):1858-65. doi: 10.1080/10428190701534440.

8

Clonal cytogenetic abnormalities in patients with chronic myeloid leukemia in complete cytogenetic response to imatinib mesylate.对甲磺酸伊马替尼完全细胞遗传学反应的慢性髓性白血病患者的克隆性细胞遗传学异常

Haematologica. 2005 Apr;90(4):556-8.

9

Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.在一例接受伊马替尼治疗的慢性髓性白血病患者中含有扩增的bcr-abl融合基因的双微体

Eur J Haematol. 2003 Apr;70(4):235-9. doi: 10.1034/j.1600-0609.2003.00046.x.

10

Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia.慢性粒细胞白血病中通过BCR-ABL非依赖性产生的甲磺酸伊马替尼耐药性。

Cancer Res. 2004 Jan 15;64(2):672-7. doi: 10.1158/0008-5472.can-03-1484.

引用本文的文献

1

Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving dasatinib.达沙替尼治疗的慢性髓性白血病患者骨髓细胞中费城染色体阴性的克隆性造血。

Leuk Res. 2010 Jun;34(6):708-13. doi: 10.1016/j.leukres.2009.08.032. Epub 2009 Oct 4.